Dr. Mathew Kiang is an Assistant Professor in the Department of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Kiangreceived his doctorate from the Department of Social and Behavioral Sciences at Harvard TH Chan School of Public Health. Before that, he received his MPH at New York University, his BA in Sociology from San Diego State University, he was a 2016 fellow at University of Chicago’s Data Science for Social Good summer fellowship, and a Fellow at the Harvard FXB Center for Health and Human Rights.

Dr. Daniel E. Ho is the William Benjamin Scott and Luna M. Scott Professor of Law at Stanford Law School, Professor of Political Science, and Senior Fellow at the Stanford Institute for Economic Policy Research. He is also Associate Director of the Stanford Institute for Human-Centered Artificial Intelligence and Director of the Regulation, Evaluation, and Governance Lab (RegLab).  With the RegLab, he has engaged in questions surrounding device regulation, regulation of machine learning products, and health policy.

Dr. David Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014.

Dr. Kavita Sarin, M.D./ Ph.D., is an Associate Professor of Dermatology. She has an academic interest in Precision Medicine, focused on the integration of genetic and clinical patient data to inform disease susceptibility, stratify prognosis, and direct treatments in dermatologic disease. Her lab applied cutting edge sequencing and imaging technologies to better understand skin cancer and rare immunologic skin diseases. She sees patients in medical dermatology at Portola Valley and directs a specialized Skin Cancer Genetics clinic.

Dr. Sarin's research encompasses two main areas:

Dr. Allison W. Kurian, M.D., M.Sc. is a Professor of Medicine and of Epidemiology and Population Health at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, trained as an intern and resident in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University.

Dr. Jung Ho Choi investigates how informational frictions and innovations have an influence on the processes and outcomes of the labor market and how these factors interact with each other. Using corporate disclosure as a major research setting, he studies how informational frictions, especially about employers, can interact with the labor market in three different dimensions:

Dr. Carolyn Rodriguez is Associate Dean for Academic Affairs, Stanford University School of Medicine, Associate Chair for Inclusion and Diversity in the Department of Psychiatry and Behavioral Sciences at Stanford University, and a Consultation-Liaison Psychiatrist at the Palo Alto Veterans Affairs. As the Director of the Translational Therapeutics Lab and Professor in the Department of Psychiatry and Behavioral Sciences, Dr. Rodriguez leads studies investigating the brain basis of severe mental disorders.

Dr. Todd P. Coleman is an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan. He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience.

Dr. Michael Rosen is a pediatric gastroenterologist and physician scientist, who has been devoted to inflammatory bowel disease (IBD) research since beginning medical training over 20 years ago. He is also Director of the Stanford Center for Pediatric IBD and Celiac Disease. Dr. Rosen has expertise crossing mucosal immunology and epithelial biology, formal training and experience in clinical and translational investigation with human biospecimens, and direct insight regarding the important clinical challenges caring for children with complicated IBD.

Dr. Nathanael Gray's Laboratory develops first-in-class chemical probes that are used to gain new biological insights into cellular processes that drive cancer and other diseases, and to pharmacologically validate potential clinically relevant targets. They take an integrative approach that combines medicinal chemistry, structural biology, biochemistry and molecular and cell biology to develop new therapeutic strategies. Their work has contributed to several approved and clinical stage drugs targeting BCR-ABL, Sphingosine-1-phosphate receptor (S1PR), EGFR, EML4-ALK and CDK7.